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Aim: To investigate the rate of laparoscopic colectomies for colon cancer using registries and population-
based studies. To provide a position paper on mini-invasive (MIS) colon cancer surgery based on the
opinion of experts leader in this ﬁeld.
Methods: A systematic review of the literature was conducted using PRISMA guidelines for the rate of
laparoscopy in colon cancer. Moreover, Delphi methodology was used to reach consensus among 35
international experts in four study rounds. Consensus was deﬁned as an agreement 75.0%. Domains of
interest included nosology, essential technical/oncological requirements, outcomes and MIS training.
Results: Forty-four studies from 42 articles were reviewed. Although it is still sub-optimal, the rate of
MIS for colon cancer increased over the years and it is currently >50% in Korea, Netherlands, UK and
Australia. The remaining European countries are un-investigated and presented lower rates with highest
variations, ranging 7e35%. Using Delphi methodology, a laparoscopic colectomy was deﬁned as a “colon
resection performed using key-hole surgery independently from the type of anastomosis”. The panel
deﬁned also the oncological requirements recognized essential for the procedure and agreed that when
performed by experienced surgeons, it should be marked as best practice in guidelines, given the
principles of oncologic surgery be respected (R0 procedure, vessel ligation and mesocolon integrity).
Conclusion: The rate of MIS colectomies for cancer in Europe should be further investigated. A panel of
leaders in this ﬁeld deﬁned laparoscopic colectomy as a best practice procedure when performed by an
experienced surgeon respecting the standards of surgical oncology.
© 2018 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical
Oncology. All rights reserved.Introduction
Colorectal cancer (CRC) is the second most frequent diagnosed
cancer with an incidence of about 450.000 new cases in Europe and
100.000 new patients/year in the US [1,2].
Currently, upfront surgical resection remains the standard of
care for non-metastatic tumors. Over the last three decades several
progresses were made for improving treatment, the survivals and
quality of life of cancer patients; the main innovation being the
outbreak of laparoscopic procedures in 1991 [3,4].
Initial concerns, including those related to a long training, the
development of port-site metastasis, the sustainability or the
adherence to surgical oncology principles [5e9], were subsequently
surmounted and in recent years a number of studies recognized the
short-term functional beneﬁts and the equivalent long-term
oncological results of this approach. In accordance with these
evidences, few national health authorities recommended the use of
mini-invasive surgery (MIS) as the preferred option for suitable
patients [9].
Surprisingly, despite these evidences and efforts, a number of
population-based studies report low rates of MIS colectomies in
European countries and in the UK [9,10].
The European Society of Surgical Oncology, ESSO, aims to
develop standards for cancer patients through its core values, as
well as its education activities, in homogenization of skills, quality
healthcare and ultimately qualiﬁcation.
In line with such mission, a core group of ESSO members aimed
this study to investigate the actual rate of MIS for colon cancer in
different continents and to provide position statements in the form
of a “White Paper” (a report provided by authoritative experts that
informs readers concisely about a this issue) on laparoscopic
colectomy. As a matter of fact, this manuscript was designed to
outline the adoption of laparoscopic colectomy for cancer globally,
but also to provide an authoritative report based on experts
consensus supporting a common deﬁnition of MIS colectomy (what
is and what is not), its technical requirements, the oncological
items that should be assured and the path of training to achieve a
gold standard. Experts were interviewed using a modiﬁed Delphi
technique. Named after the Oracle at Delphi, this approach is an
internationally validated group facilitation that searches for aconsensus through a series of interview rounds and allows the
collection of experts' opinions [11]. Accordingly, and on the basis of
an ESSO initiative, experts were selectedmainly, but not exclusively
in the Eurozone.
Methods
PRISMA data source and search strategies
This investigation has been conducted adhering to the PRISMA
Statement for review and meta-analysis (Fig. 1). We conducted a
systematic review of the literature by searching PubMed database
using the following search strategy: “colonic neoplasms” [MeSH
Terms] AND “registries” [MeSH Terms] AND (“surgical procedures,
operative” [MeSH Terms] OR “general surgery” [MeSH Terms]) NOT
“robotic surgical proceduresv” [MeSH Terms] AND “europe” [MeSH
Terms] AND (“humans” [MeSH Terms] AND English [lang]); “lapa-
roscopy/epidemiology” [MeSH Major Topic] AND “colonic neo-
plasms” [MeSH Terms] NOT “robotic surgical procedures” [MeSH
Terms] AND (“humans” [MeSH Terms] AND English [lang]); “lapa-
roscopy/statistics and numerical data” [MeSH] AND “colonic neo-
plasms” [MeSH Terms] NOT “robotic surgical procedures” [MeSH
Terms] AND (“2007/05/08” [PDAT]: “2017/05/04” [PDAT]) AND
(“humans” [MeSH Terms] AND English [lang]); “laparoscopy/trends”
[MeSH] AND “colonic neoplasms” [MeSH Terms] NOT “robotic sur-
gical procedures” [MeSHTerms] AND (“humans” [MeSH Terms] AND
English [lang]) and “laparoscopy/utilization” [MeSH] AND “colonic
neoplasms” [MeSH Terms] NOT “robotic surgical procedures” [MeSH
Terms] AND (“humans” [MeSH Terms] AND English [lang]).
If studies missed data from any European countries, a further
search for “laparoscopic colectomy rate in …” was repeated in
PubMed including the members European union as listed in
https://europa.eu/european-union/about-eu/countries en.
Signiﬁcant references from retrieved publications were also
included. Duplicate references were removed by manual search.
Authors of this study were blinded to authors' and journals' name
while reviewing the series, and did not have any contacts with the
authors of the included papers. We did not consider any journal's
scores (e.g., journal's Impact Factors) of the published series as
exclusion criteria for this review.
Fig. 1. PRISMA ﬂow chart for systematic review investigating the burden of mini-invasive surgery.
L. Lorenzon et al. / European Journal of Surgical Oncology 44 (2018) 469e483 471The systematic review was aimed to detect the rate of MIS
surgery for colon cancer independently from the time of investi-
gation, deﬁnition of the procedure, conversion surgery or country.
Furthermore, we focused our analysis on registries, population-
based/multi-institutional studies. Accordingly, manuscripts
providing exclusively open or laparoscopic series, case-control/case-matched studies and RCTs were excluded (Supplement
File 1, Exclusion List). For the purpose of this study, each article
was assessed by evaluation of the title and the abstract; if the latter
was uninformative, the full paper was reviewed.
Moreover, a systematic review of the principal national and
international surgical societies guidelines published on PubMed or
L. Lorenzon et al. / European Journal of Surgical Oncology 44 (2018) 469e483472available in Internet using standard search engines (i.e. Google,
keywords: “laparoscopy”, “colon cancer” and “scientiﬁc society”
and “Guidelines”) has been conducted aiming to detect societies'
recommendations (limit to English language).
PRISMA outcome measures
Main outcome measure of the systematic review was the rate
of MIS. Whenever possible we focused on colon cancers (thus
excluding rectal cancer); also, emergency resections were outlined
as well as time-period range or geographic variations.
Delphi study design
On March 2016, ESSO board members approved the study and
appointed a coordinator (DD). The coordinator designed a MIS task
force who was in charge of literature review, questionnaires
development and data analysis (LL, AB, RDL). Study begun on April
2016 when the task force selected the topics for the Delphi study
through a bibliographic search (full details in Supplement File 2).
Topics were selected on the basis of the “White Paper” parts, thus
they should encompass deﬁnition, a discussion of relevant issues
for targeted readers (surgical oncologists), contain technical details
and quote signiﬁcant references. One author (LL) collected litera-
ture data, while two others evaluated the papers independently (AB
and RDL). Literature review focused on 2 main topic areas to
structure the questionnaires (nosology: laparoscopy deﬁnition,
anastomoses, extraction site, best practice/guidelines, essential
technical/oncological items, and outcome: right colon cancer, left
colon cancer, short term and long term outcomes, use of adjuvant
therapy and ERAS protocols). A further “domain” (training) was
integrated in Round 2 on the basis of experts' preferences selection.
Panel of experts
A panel of experts was selected by the ESSO board, supported by
ETC committee members and included leading surgeons in MIS
colectomy with an outstanding clinical background and scientiﬁc
track record from different European and extra-European countries
(Mini-Invasive Surgery Collaborators eMISiCOL- Task Force).
Although there are no clear guidelines regarding the minimum
number of panelists to be included, for the purpose of this inves-
tigation a panel size of more than 30 experts was considered as
appropriate. Panel composition (see Collaborators List) was
designed in accordance with international recommendations [12].
Invitation were mailed to possible participants by ESSO chief
operating ofﬁcer and study coordinator, along with a brief expla-
nation of the study goals, the bibliographic search that driven the
investigation, the deﬁnition of the consensus and the domain of
interest (see supplementary materials).
Questionnaires and rounds
According to the Delphi methodology an un-deﬁned number of
rounds should be performed, until a consensus is reached; MIS task
force designed this study according to a modiﬁed Delphi technique
consisting in 3 rounds of self-administered questionnaire and a ﬁnal
meeting held in Berlin on September 2017 for the ﬁnal presentation
of the consensus statements [13]. Questionnaires were emailed to
participants in all rounds. Reminders were sent to non-responders
on a regular basis with a maximum of three reminders/person.
Questionnaires were designedwith different type of answers (yes or
no, check-off or open), including also Likert scales (ranging from 1:
complete disagreement to 7: complete agreement), implemented by
marking red the “dis-agreement area” and green the “agreementarea” of choice and specifying the “neutral” choice (n 4). Full ques-
tionnaires - as theywere administered to the experts-are available in
Supplement File 3. Questionnaire in Round 1 consisted of 5 parts:
Part A aimed to demographics, volume of MIS and training, Part B
focused on deﬁnitions, Part C on the clinical and technical aspects of
laparoscopic resection for colon cancer, Part D on laparoscopic
resection for colon cancer in clinical practice and ﬁnally Part E on
personal considerations and Delphi rating. Subsequent rounds were
introduced by a brief paragraph for iteration of results and included
remarks and suggestions from the previous rounds; of note, ques-
tions where consensus was reached during the ﬁrst round were
omitted. ESSO chief operating ofﬁcer was in charge of emailing
questionnaires during the ﬁrst 2 rounds in order to respect the an-
onymity of the panel. Questionnaire in Round 2 consisted of 5 parts:
Part B focused on deﬁnitions, Part C on the clinical and technical
aspects of laparoscopic resection for colon cancer, Part D on lapa-
roscopic resection for colon cancer in clinical practice, Part E on
training and Part F on personal considerations and Delphi rating.
Round 1 ended on May 2017, data were analyzed and following a
second questionnaire was developed on June 2017. Round 2 ended
on July 2017 and a subsequent brief Round 3 consisting exclusively in
5 questions was emailed on August 2017. As previously stated, all
members of the panel were invited to a face-to-face meeting during
the ESCP Congress; however, six attended and other two joined via
Skype connection, the remaining received iteration by email corre-
spondence. During this brief consultation all statements produced so
far were reviewed and extensively discussed between panel mem-
bers, and itwas agreed to implement the studywith a concise Round
4 consisting in seven questions. Study ended on October 2017.
Consensus
Consensus for single/multiple choice questions was deﬁned
as an agreement equal or greater than 75% between respondents
(number of identical answers divided by the number of re-
spondents), whereas for Likert scale, it was deﬁned as an agree-
ment equal or greater than 75% for values ranging 6e7; on the other
hand dis-agreement was deﬁned as equal or greater than 75% for
values 1e2 on the scale (75% of the ratings being in the lowest or
highest tertile [13]).
Statistical methods
For the purpose of data collection and analysis a Database for
PRISMA systematic review and another Database for Delphi
investigation were constituted. Data from the four rounds were
reported and analyzed separately. Continuous variables were
analyzed usingmeans and standard deviations and compared using
the T Test, whereas categorical variables were analyzed using fre-
quencies and percents. For each consensus statement we reported
the consensus rate, and for Likert scales it included themean, mode
and median values, the coefﬁcient of variation (CV) and the inter-
quartile range (IQR). Databases and statistical analyses were
obtained using Excel (Microsoft Corporation, USA), MedCalc
(MariaKerke, Belgium) and SPSS (IBM, Armonk USA) software. All
tests were performed two-tailed and a p value < 0.05 was consid-
ered as statistically signiﬁcant.
Results
The Adoption of MIS for colon cancer: a systematic review
Table 1 shows the 42 articles included in the systematic review
[9,10,14e53]. Forty-four studies reviewed included 3.945.263
colorectal cancer patients, with a mean number of 89665.1/study
Table 1
Literature reporting the burden of laparoscopy for colon cancer: results from registries and population based studies.
N Author Title Journal Country Setting N of
Patients
Rate of
Laparoscopic
Patients
Years of
Investigation
Ref
1 Aslani N, Lobo-
Prabhu K, Heidary B
et al.
Outcomes of laparoscopic colon cancer surgery in a
population-based cohort in British Columbia: are they as
good as the clinical trials?
Am J Surg
2012;204:411e5.
Canada Elective +
Emergency
2013 15.0 Range TP: 2e25
Emergency 0.74
2003e2008 [14]
2 Sippey M, Spaniolas
K, Manwaring ML et
al.
Surgical resident involvement differentially affects patient
outcomes in laparoscopic and open colectomy for
malignancy.
Am J Surg
2016;211:1026e34.
USA Elective 26190 37.4 2005e2012 [15]
3 Khalid U, Evans MD,
Williams GL et al.
Variability in management of T1 colorectal cancer in Wales. Ann R Coll Surg Engl
2013;95:477e80.
UK (Wales) 95 (T1 cancers) 51.0 2009e2011 [16]
4 Rea JD, Cone MM,
Diggs BS et al.
Utilization of laparoscopic colectomy in the United States
before and after the clinical outcomes of surgical therapy
study group trial.
Ann Surg 2011;254:281
e8.
USA Elective 741817 7.6 Range TP: 2.3e8.9 2001e2007 [17]
5 Simorov A, Shaligram
A, Shostrom V et al.
Laparoscopic colon resection trends in utilization and rate of
conversion to open procedure: a national database review
of academic medical centers
Ann Surg 2012;256:463 USA 85712 42.2 Range TP: 37.5e44.1 2008e2011 [18]
6 Krarup PM,
Nordholm-
Carstensen A,
Jorgensen LN et al.
Anastomotic leak increases distant recurrence and long-
term mortality after curative resection for colonic cancer: a
nationwide cohort study.
Ann Surg 2014;259:930
e8.
Netherlands Elective +
Emergency
9333 16.7 2001e2008 [19]
7 Bilimoria KY,
Bentrem DJ, Nelson H
et al.
Use and outcomes of laparoscopic-assisted colectomy for
cancer in the United States.
Arch Surg
2008;143:832e9.
USA 242419 4.5 Range TP: 3.8e5.2 1998e2002 [20]
8 Cone MM, Herzig DO,
Diggs BS et al.
Dramatic decreases in mortality from laparoscopic colon
resections based on data from the Nationwide Inpatient
Sample.
Arch Surg
2011;146:594e9.
USA Elective +
Emergency
1314696 6.8 2002e2007 [21]
9 Kang CY, Halabi WJ,
Luo R et al.
Laparoscopic colorectal surgery: a better look into the latest
trends.
Arch Surg
2012;147:724e31.
USA 244098 27.6 Range TP: 13.8e42.6 2007; 2009 [22]
10 Dik VK, Aarts MJ, Van
Grevenstein WM et
al.
Association between socioeconomic status, surgical
treatment and mortality in patients with colorectal cancer.
Br J Surg
2014;101:1173e82.
Netherlands Elective +
Emergency
4422 25.8 2005e2010 [23]
11 Faiz O, Haji A, Bottle A
et al.
Elective colonic surgery for cancer in the elderly: an
investigation into postoperative mortality in English NHS
hospitals between 1996 and 2007.
Colorectal Dis
2011;13:779e85.
UK Elective 28746 3.0 (pts > 75 yrs)
Range TP: 0.4e11.8
1996e2007 [24]
12 Chan BP, Gomes T,
Musselman RP et al.
Trends in colon cancer surgery in Ontario: 2002e2009. Colorectal Dis
2012;14:e708e12.
Canada Elective 16998 23.2 2002e2009 [25]
13 Krarup PM, Jorgensen
LN, Andreasen AH et
al.
A nationwide study on anastomotic leakage after colonic
cancer surgery.
Colorectal Dis
2012;14:e661e7.
Denmark 9333 17.3 Range TP: 2.0e41.0 2001e2008 [26]
14 Tanis PJ, Paulino
Pereira NR, van Hooft
JE et al.
Resection of obstructive left-sided colon cancer at a national
level: a prospective analysis of short-term outcomes in
1,816 patients.
Dig Surg 2015;32:317
e24.
Netherlands Emergency 1485 9.2 2009e2012 [27]
15 Hansen DG, Fox JP,
Gross CP et al.
Hospital readmissions and emergency department visits
following laparoscopic and open colon resection for cancer.
Dis Colon Rectum
2013;56:1053e61.
USA Elective 6760 49.0 2008e2009 [28]
16 Dobbins TA, Young
JM, Solomon MJ.
Uptake and outcomes of laparoscopically assisted resection
for colon and rectal cancer in Australia: a population-based
study.
Dis Colon Rectum
2014;57:415e22.
Australia Elective +
Emergency
20977 6.1 Range TP: 1.5e20.7
Emergency 0.45
2000e2008 [29]
17 Moghadamyeghaneh
Z, Carmichael JC, Mills
S et al.
Variations in laparoscopic colectomy ttilization in the
United States.
Dis Colon Rectum
2015;58:950e6.
USA Elective 192063 49.6 Range TP: 45e53.5 2009e2012 [30]
18 Krarup PM,
Nordholm-
Carstensen A,
Jorgensen LN et al.
Association of comorbidity with anastomotic leak, 30-day
mortality, and length of stay in elective surgery for colonic
cancer: a nationwide cohort study.
Dis Colon Rectum
2015;58:668e76.
Netherlands Elective 8597 18.7 2001e2008 [31]
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Table 1 (continued )
N Author Title Journal Country Setting N of
Patients
Rate of
Laparoscopic
Patients
Years of
Investigation
Ref
19 Doumouras AG, Saleh
F, Eskicioglu C et al.
Neighborhood variation in the utilization of laparoscopy for
the treatment of colon cancer.
Dis Colon Rectum
2016;59:781e8.
Canada Elective 9969 43.3 2008e2012 [32]
20 SCOAP Collaborative. Adoption of laparoscopy for elective colorectal resection: a
report from the Surgical Care Outcomes Assessment
Program.
J Am Coll Surg
2012;214:909e18.
USA Elective 9705 38.0 Range TP: 23.3e41.6 2005e2010 [33]
21 Sticca RP, Alberts SR,
Mahoney MR et al.
Current use and surgical efﬁcacy of laparoscopic colectomy
in colon cancer.
J Am Coll Surg
2013;217:56e62.
USA Elective 3393 37.7 2004e2009 [34]
22 Damle RN, Macomber
CW, Flahive JM et al.
Surgeon volume and elective resection for colon cancer: an
analysis of outcomes and use of laparoscopy.
J Am Coll Surg
2014;218:1223e30.
USA Elective 17749 45.0 Range TP: 42e48 2008e2011 [35]
23 Reames BN, Sheetz
KH, Waits SA et al.
Geographic variation in use of laparoscopic colectomy for
colon cancer.
J Clin Oncol
2014;32:3667e72.
USA Elective +
Emergency
93786 32.5 Range GV: 0e66.8 2009e2010 [36]
24 Park SJ, Lee KY, Lee
SH.
Laparoscopic surgery for colorectal cancer in Korea:
nationwide data from 2008e2013.
J Minim Invasive Surg
2015;18:39e43.
Korea 112509 55.7 Range TP: 43.4e64.5 2008e2013 [37]
25 Yeo H, Niland J, Milne
D et al.
Incidence of minimally invasive colorectal cancer surgery at
National Comprehensive Cancer Network centers.
J Natl Cancer Inst
2015;107:362.
USA Elective 2493 36.0 Range TP: 35e51 2005e2010 [38]
26 Gruber K, Soliman AS,
Schmid K et al.
Disparities in the utilization of laparoscopic surgery for
colon cancer in rural Nebraska: a call for placement and
training of rural general surgeons.
J Rural Health
2015;31:392e400.
USA Elective +
Emergency
1062 28.0
Emergency 10.2
2008e2011 [39]
27 Henneman D, Ten
Berge MG, Snijders
HS et al.
Safety of elective colorectal cancer surgery: non-surgical
complications and colectomies are targets for quality
improvement.
J Surg Oncol
2014;109:567e73.
Netherlands Elective 10184 53.0 2011e2013 [40]
28 Sammour T, Jones IT,
Gibbs P et al.
Comparing oncological outcomes of laparoscopic versus
open surgery for colon cancer: analysis of a large
prospective clinical database.
J Surg Oncol
2015;111:891e8.
Australia Elective 1106 50.6 Range TP: 7e67 2003e2009 [41]
Babaei M, Balavarca
Y, Jansen L et al.
Minimally invasive colorectal cancer surgery in Europe:
implementation and outcomes.
Medicine (Baltimore)
2016;95:e3812. NNCR
(Population-based
registry)
Netherlands Elective 58927 39.0 2009e2014 [42]
Medicine (Baltimore)
2016;95:e3812.SCRCR
(Population-based
registry)
Sweden Elective 35690 7.0 2007e2014
]29 Medicine (Baltimore)
2016;95:e3812.
NCR (Population-
based registry)
Norway Elective 15078 23.0 2007e2012
30 Turagava J, Sammour
T, Al-Herz F et al.a
Short-term outcomes of laparoscopic resection for colon
cancer in a provincial New Zealand hospital.
N Z Med J 2012;125:17
e26.
New Zealand Elective 536 25.7 2001e2010 [43]
31 Lim SB, Choi HS, Jeong
SY et al.
Feasibility of laparoscopic techniques as the surgical
approach of choice for primary colorectal cancer: an
analysis of 570 consecutive cases.
Surg Endosc
2008;22:2588e95.
Korea 2820 20.1 Range TP: 2.4e66.1 2000e2006 [44]
32 Kemp JA, Finlayson
SR.
Nationwide trends in laparoscopic colectomy from 2000 to
2004.
Surg Endosc
2008;22:1181e7.
USA Elective 301229 Range TP: 1.4e4.3 2000e2004 [45]
33 Stefanou AJ, Reickert
CA, Velanovich V et al.
Laparoscopic colectomy signiﬁcantly decreases length of
stay compared with open operation.
Surg Endosc
2012;26:144e8.
USA Elective +
Emergency
45654 27.3 Emergency 3.6 2005e2009 [46]
34 Alnasser M,
Schneider EB,
Gearhart SL et al.
National disparities in laparoscopic colorectal procedures
for colon cancer.
Surg Endosc
2014;28:49e57.
USA Elective +
Emergency
14502 32.3 2009 [47]
35 Stormark K, Søreide
K, Søreide JA et al.
Nationwide implementation of laparoscopic surgery for
colon cancer: short-term outcomes and long-term survival
in a population-based cohort.
Surg Endosc
2016;30:4853e4864.
Norway Elective +
Emergency
8707 27.1 Range TP: 16e36
Emergency 6.1
2007e2010 [48]
36 Askari A, Nachiappan
S, Currie A et al.
Selection for laparoscopic resection confers a survival
beneﬁt in colorectal cancer surgery in England.
Surg Endosc
2016;30:3839e47.
UK 141682 20.9 Range TP: 0.4e48 2001e2011 [9]
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to 2014. Four continents were represented, however, a prevalence
of studies from the USA was reported (18 out of 44 investigations,
40.9%). Among the European countries, the Netherlands reported
the vast majority of studies, followed by UK. Despite this, the actual
rate of MIS in the vast majority of European countries still needs
further investigation. Similarly, evidence was lacking in Asiatic
studies with the exception of Korea.
All studies were based on multiple-institutions (registries/
population-based studies) with the sole exception of New Zealand;
the study by Turagava and co-authors was included nevertheless,
however, since they reported the results of the only hospital of the
region [43].
Of note, we extrapolated the rate of MIS colectomies in each
study and presented the result as representative of the country,
although few studies were based exclusively on registry of a
determined region/province. Whenever possible, however, we
highlighted difference in geographic variations, Table 1.
The overall mean rate of MIS procedures was 28.4% (median
27.6, SD 15.9, range 1.5e55.7%), including elective and emergency
resections. The vast majority of studies were indeed focused on
elective resections, reporting a mean rate of laparoscopic proced-
ures of 32.4%. As expected, when data regarding emergency pro-
cedures were extrapolated [10,14,19,21,23,27,29,36,39,46e48,50]
the rate of MIS reported was extremely low: mean value 6.5%
(median 7.0%), T test elective vs emergency p value 0.00004.
Fig. 2 shows the rate of MIS in different countries and different
studies over the years. We could provide a time variation for all the
countries investigated, with the sole exception of Spain, Sweden and
New-Zealand [42,43,53]. As documented in the Figure, we could
observe the rate of MIS increased over the years in all countries.
However, in Europe is currently still sub-optimal since it ranges
20.0e35.6 Italy [10,51], Spain and Norway [42,48,49,53]. Opposite,
this rate is signiﬁcantly lower in Sweden e about 7.0% [42] - and
higher in the Netherlands e (53.0%) and in the UK [40,52].
Colon cancer MIS and society guidelines
Table 2 shows the results of the bibliographic search through
scientiﬁc society guidelines. We retrieved 13 guidelines focused on
colorectal cancer treatment representing all the continents [54e66],
documenting also from this analysis a prevalence of American re-
ports (30.7%), consistently with the language selection criteria
adopted for this search. Although two guidelines were un-
informative regarding MIS and recommendation for clinical prac-
tice [55,56], the vast majority of scientiﬁc societies recommend the
use of laparoscopic resection for colon cancer based on the surgeon's
documented experience as well as on patient- and tumor-speciﬁc
factors. Indeed, the main concern of scientiﬁc group were: sur-
geon's training, transverse tumorand resection ofmetastatic disease/
bulky tumor if a curative resection can be achieved using open
approach. Other concerns were related to laparoscopic staging of
livermetastases, obese patients and the difﬁculties of a D3dissection.
Delphi results and consensus statements
Adhesion rate for Round 1 was of 91.2%, for Round 2was of 91.1%
and ﬁnally in Round 3 e Round 4 was of 88.2%. Table 3 shows the
roadmap of the experts invited to join the Delphi. These data were
collected at the beginning of Round 1 and, although few collabo-
rators did not disclose their demographic data at that stage, we
could provide a signiﬁcant representation of the panel composition.
The mean age of the surgeons was about 50.0 years afﬁliated to
University Hospitals in more than a half of the cases; interestingly,
the totality of the experts were males. All European zones were
Fig. 2. Rates of MIS procedures for colon cancers in different countries over the years.
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Table 2
Scientiﬁc Societies Guidelines for the surgical treatment of colon cancer.
N Society Year Reference Country MIS recommendation Ref
1 ASCRS 2012 Chang GJ, Kaiser AM, Mills S et al. Practice parameters
for the management of colon cancer. Dis Colon Rectum
2012; 55: 831e843.
USA Laparoscopic and open colectomy achieve equivalent
oncological outcomes for localized colon cancer. The use of
the laparoscopic approach should be based on the surgeon’s
documented experience in laparoscopic surgery as well as on
patient- and tumor-speciﬁc factors. Grade of
Recommendation: 1A.
[54]
2 EAST 2016 Ferrada P, Patel MB, Poylin V et al. Surgery or stenting
for colonic obstruction: A practice management
guideline from the Eastern Association for the Surgery
of Trauma. J Trauma Acute Care Surg 2016, 80: 659
e664.
USA n/a [55]
3 ECCO 2017 Beets G, Sebag-Monteﬁore D, Andritsch A et al. ECCO
Essential Requirements for Quality Cancer Care:
Colorectal Cancer. A critical review. Crit Rev Oncol
Hematol 2017; 110: 81e93.
Europe n/a [56]
4 ERAS 2012 Gustafsson UO, Scott MJ, Schwenk W et al. Guidelines
for perioperative care in elective colonic surgery:
Enhanced Recovery After Surgery (ERAS) Society
recommendations. Clinical Nutrition 2012; 31:783
e800.
America/Europe
/UK/
New Zealand
Summary and recommendation: Laparoscopic surgery for
colonic resections is recommended if the expertise is
available. Evidence level: Oncology: High. Morbidity: Low
(inconsistency). Recovery/LOSH: Moderate (inconsistency)
Recommendation grade: Strong
[57]
5 ESMO 2013 Labianca R, Nordlinger, Beretta GD et al. Early colon
cancer: ESMO Clinical Practice Guidelines for diagnosis,
treatment and follow-up. Ann Oncol 2013;
24(Supplement 6): vi64evi72.
Europe Laparoscopic approach has now received wide acceptance for
several types of surgical procedures of major abdominal
surgery. Laparoscopic colectomy can be safely carried out for
colon cancer, particularly for left-sided cancer [I]. For right-
sided colonic cancers, the beneﬁt is less obvious since
anastomosismust be hand sewn, which requires a laparotomy
[IV]. The long-term oncological results of laparoscopic
colectomy are similar to those of the conventional approach
[I]. Advantages of laparoscopy over the conventional
approach are reduced pain, reduced length of hospital stay
and reduced duration of ileus [II]. It is recognised that a
laparoscopic approach should only be carried out if the
following criteria are met:
(i) technically experienced surgeons,
(ii) lack of serious abdominal adhesion due to prior major
abdominal surgery,
(iii) no locally advanced disease and/or acute bowel
obstruction or perforation.
[58]
6 EURECCA 2014 van de Velde CJH, Boelens PG, Borras JM et al. EURECCA
colorectal: Multidisciplinary management: European
consensus conference colon & rectum. Eur J Cancer
2014; 50: 1.e1e 1.e34.
Europe Laparoscopic colon cancer surgery results in several beneﬁts
in the direct postoperative period in comparison to open
colonic surgery. Laparoscopic surgery for colon cancer is safe
and as effective as open surgery. Given the prolonged learning
curve associated with laparoscopic surgery, it is very
important that the surgeon is adequately trained before
practising this technique on his or her own. Laparoscopic
resection has some disadvantages such as a long learning
curve, longer duration of operation and higher operative
costs. Restrictions in laparoscopic technique are related to
previous abdominal surgery (adhesions), and to locally
advanced disease (relative contraindication). With minimal
consensus, it was agreed that the indication for laparoscopic
surgery is not stage dependent and that even combined
laparoscopic segmental colon resection and liver
metastasectomy can be safely performed in stage IV in expert
centers.
[59]
7 EAES 2012 Agresta F, Ansaloni A, Baiocchi GL et al. Laparoscopic
approach to acute abdomen from the Consensus
Development Conference of the Societa Italiana di
Chirurgia Endoscopica e nuove tecnologie (SICE),
Associazione Chirurghi Ospedalieri Italiani (ACOI),
Societa Italiana di Chirurgia (SIC), Societa Italiana di
Chirurgia d’Urgenza e del Trauma (SICUT), Societa
Italiana di Chirurgia nell’Ospedalita Privata (SICOP), and
the European Association for Endoscopic Surgery
(EAES). Surg Endosc 2012; 26:2134e64.
Italy n/a [60]
8 HeSMO 2016 Xynosa E, Gouvasb N, Triantopoulouc C et al. Clinical
practice guidelines for the surgical management of
colon cancer: a consensus statement of the Hellenic and
Cypriot Colorectal Cancer Study Group by the HeSMO.
Ann Gastroenterol 2016; 29: 3e17.
Greece Laparoscopic surgery for uncomplicated cancer of the right
and left colon offers faster recovery and less morbidity as
compared to the open approach. Oncological results are
similar between the two approaches, provided that the
surgical team involved is well trained and serves a large
volume of cases (LOE I, SOR A) (ROVC: 96%) Laparoscopic
resection of tumors of the transverse colon may be technically
demanding and the quality of specimen may not be optimal
[61]
(continued on next page)
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Table 2 (continued )
N Society Year Reference Country MIS recommendation Ref
due to difﬁcult dissection, ligation and division of the middle
colic vessels at their origin (LOE III, SOR A) (ROVC: 93%)
Laparoscopic approach is not indicated for bulky and
advanced colon lesions, where curative resection can be
achieved by open surgery (LOE I, SOR A) (ROVC: 94.5%) Small
lesions not visible by laparoscopy should be marked prior to
surgery (LOE III, SOR A) (ROVC: 99%) As conversion may be
associated with increased morbidity as compared both to
laparoscopically completed and to open approach, predictive
factors for conversion, such as obesity or ASA IIIeIV cases,
should be identiﬁed prior to laparoscopy (LOE II, SOR B)
(ROVC: 92%) Early or pre-emptive as opposed to late
conversion does not seem to be associated with increased
morbidity (LOE IV, SOR B) (ROVC: 89%)
9 HeSMO
(Stage IV
Colon Cancer)
2016 Dervenisa C, Xynosb E, Sotiropoulosc G et al. Clinical
practice guidelines for the management of metastatic
colorectal cancer: a consensus statement of the Hellenic
Society of Medical Oncologists (HeSMO). Ann
Gastroenterol 2016; 29: 390e416.
Greece Laparoscopic staging of liver metastasis with the use of US is
of limited accuracy (LOE I, SOR A) (ROVC: 84%) Due to lack of
high level of evidence, the laparoscopic approach for the
resection of hepatic metastases is not recommended, unless
performed by a very experienced surgical team andwithin the
context of clinical trials (LOE IV, SOR D) (ROVC: 97%) In
selected cases and in experienced centers, a laparoscopic
approach can be applied both for the resection of primary and
hepatic metastases, either by the one- or two- stage approach
[62]
10 JSCCR 2017 WatanabeT, Muro K, Ajioka Y et al. Japanese Society for
Cancer of the Colon and Rectum (JSCCR) guidelines 2016
for the treatment of colorectal cancer. Int J Clin Oncol
2017; doi 10.1007/s10147-017-1101-6.
Japan The indications for laparoscopic surgery are determined by
considering the surgeon’s experience and skills, as well as
tumor factors, such as the location and degree of progression
of the cancer, and patient factors, such as obesity and history
of open abdominal surgery. Clinical Question: is laparoscopic
surgery for colorectal cancer effective?
 According to randomized controlled trials held overseas and
the Cochrane Database of Systematic Reviews, the safety and
long-term outcome of laparoscopic surgery in cases of colonic
and RS cancers are similar to those in open surgery. As D3
dissection is difﬁcult under laparoscopic conditions,
laparoscopic surgery for cStage IIecStage III disease should be
implemented when it is considered that the individual
surgical team is sufﬁciently experienced. Laparoscopic
surgery is also difﬁcult in patients with transverse colon
cancer, in severely obese patients, and in patients with severe
adhesions.
 The efﬁcacy and safety of laparoscopic surgery for rectal
cancer has not been established. Ideally, appropriately
planned clinical trials should be implemented.
(Recommendation/Evidence level 1B).
[63]
11 NCCN 2017 www.nccn.org USA Minimal Invasive Surgery can be considered based on the
following criteria: The surgeon has experience in performing
laparoscopic assisted colorectal operations. There is no locally
advanced disease. It is not indicated for acute bowel cancer
obstruction or perforation from cancer. Throughout
abdominal exploration is required. Consider preoperative
marking of the lesion(s).
[64]
12 SAGES 2012 www.sages.org USA One of the most controversial issues in minimally invasive
surgery has been the implementation of laparoscopic
techniques for resection of curable colorectal malignancies.
Initial concerns included the potential violation of oncologic
principles, the effects of carbon dioxide insufﬂation, and the
phenomenon of port site tumor recurrence. Basic science
research and large randomized controlled trials are now
demonstrating that these fears were unjustiﬁed. The
laparoscopic approach, however, involves a steep learning
curve and requires the surgeon and ancillary operating room
staff to have advanced skills in laparoscopy. When
approaching colon resection laparoscopically, every effort
should be made to localize the tumor preoperatively. Small
lesions should be marked endoscopically with permanent
tattoos before surgery to maximize the surgeon’s ability to
identify the lesion. Surgeons should be prepared to use
colonoscopy intraoperatively if lesion localization is
uncertain. (++OO, strong) We recommend that laparoscopic
resection follow standard oncologic principles: proximal
ligation of the primary arterial supply to the segment
harboring the cancer, appropriate proximal and distal
margins, and adequate lymphadenectomy. (++++, strong) For
locally advanced adherent colon and rectal tumors, an en bloc
resection is recommended. We suggest an open approach if a
[65]
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Table 2 (continued )
N Society Year Reference Country MIS recommendation Ref
laparoscopic en bloc resection cannot be performed
adequately. (++OO, weak) We recommend that patients with
an obstructing right or transverse colon cancer undergo a
right or extended right colectomy. The open approach is
required if the laparoscopic approach will not result in an
oncologically sound resection. (++OO, strong) We suggest that
for patients with an obstructing left-sided colon cancer, the
procedure be individualized according to clinical factors.
Colonic stenting may increase the likelihood of completing a
one-stage procedure and may decrease the likelihood of an
end colostomy. (+++O, weak) Before surgeons apply the
laparoscopic approach for the resection of curable colon and
rectal cancer, they must have adequate knowledge, training,
and experience in laparoscopic techniques and oncologic
principles. (+++O, strong)
13 SIGN 2016 Scottish Intercollegiate Guidelines Network (SIGN).
Diagnosis and management of colorectal cancer.
Edinburgh: SIGN; 2011. (SIGN publication no. 126).
[December 2011]. Available from URL: http://
www.sign.ac.uk
Scotland Laparoscopic and open surgery can be offered for resection of
colorectal cancer.
[66]
Table 3
Delphi study and panel composition e the roadmap.
Age
Mean; SD 49.5 7.9
Median 50.0
SD 7.8
Range 37.0 65.0
Eurozone (Eurovoc Regions) n %
Southern Europe 8.0 26.7
Western Europe 13.0 43.3
Eastern Europe 6.0 20.0
Northern Europe 2.0 6.7
Other (USA) 1.0 3.3
Total 30.0 100.0
Institution n %
University 16.0 55.2
Community 9.0 31.0
Private 2.0 6.9
Other 2.0 6.9
Total 29.0 100.0
Training in Colorectal Cancer n %
Yes 26.0 86.7
No 4.0 13.3
Total 30.0 100.0
Years of Practice in Colorectal Cancer n %
<5 yrs 0.0 0.0
Range 6-10 8.0 26.7
>10 22.0 73.3
Total 30.0 100.0
Hospital Colorectal Cancer Volume n %
<30 0.0 0.0
Range 31e50 3.0 10.3
Range 51e100 6.0 20.7
>101 20.0 69.0
Total Fill 29.0 100.0
Personal Rate of Laparoscopic Colorectal Cancer n %
<30 2.0 6.9
Range 31e50 1.0 3.4
Range 51e80 4.0 13.8
>80 22.0 75.9
Total 29.0 100.0
Other Colorectal Cancer Surgeons at Institution n %
0 0.0 0.0
1 8.0 27.6
>2 21.0 72.4
Total 29.0 100.0
Conversion Rate
Mean; SD 6.5 5.4
Median 5.0
Range 0.0 25.0
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colorectal surgery, with more than 10 years in colorectal cancer
care (73.3%). Most importantly, the vast majority of surgeons came
from high volume institutions, had a signiﬁcant rate of laparoscopic
procedure/year and a minimal conversion rate. Most importantly,
the greater percentages of their afﬁliation met the most recent
ECCO recommendations regarding the minimum number of sur-
geons to be involved in colorectal cancer care (>2 surgeons) [56].
On the other hand, Table 4 shows the consensus statements that
we could provide in a series of four rounds. In line with this paper
aim, experts agreed in a common deﬁnition of laparoscopic colec-
tomy as “a colon resection performed using key-hole surgery inde-
pendently from the type of anastomosis”; opposite it was agreed that
all other “hand-assisted procedures or resections characterized by few
laparoscopic maneuvers followed by open resection should not be
marked as laparoscopic colectomies”.
A consensus was reached also for the deﬁnition of conversion
surgery as “an un-planned interruption of laparoscopic maneuvers that
requires a laparotomy” although almost the totality supported the idea
that an external anastomoses is not a criterion for deﬁning conversion.
In order to perform a laparoscopic colectomy which requires a
number of devices; the experts rated few items and agreed that the
advanced energy device, a 30 scope and the wound retractor/
protector could be assessed, in their experience, as essential.
Similarly, we consulted the panel regarding the principles of
surgical oncology, and a consensus was reached for a central/high
ligation of the vascular pedicles and a completemesocolon excision
for late stages tumors (i.e.  cT3Nþ); ﬁnally, the totality of the
experts agreed that it should be respected the embryologically
planes to create an intact envelope containing all the nodes. In
relation to the surgical procedure, it was agreed that reports should
be check-listed and should include a number of items as the exact
tumor location, vessel ligation, integrity of the mesocolon in order
to standardize and homogenize also the reporting of the procedure.
We also brieﬂy discussed evidences in relation to possible ad-
vantages or pitfalls, and as expected, the experts recognized the
results of RCTs in relation to the short-term functional beneﬁts and
the non-inferiority of long term oncological results. Most impor-
tantly, given the following deﬁnitions: a) best practice - a technique
that has been accepted as superior because it produces improved
results comparing to those achieved by other means and b)
guidelines - statements generated by the evidences aimed to guide
decisions and criteria regarding diagnosis, management, and
Table 4
Consensus statements from Delphi study.
Statement Consensus Round
Statement A: Deﬁnition of Laparoscopic Colectomy
Laparoscopic colectomy is a colon resection performed using key-hole surgery independently from
the type of anastomosis
Range 6e7 80.0%, Mean 6.2, Median 7.0,
Mode 7.0, CV<0.5, IQR 0.8
Round 1
Opposite All other hand-assisted procedures or resections characterized by few laparoscopic maneuvers
followed by open resection should not be marked as laparoscopic colectomies
Range 6e7 93.3%, Mean 6.5, Median 7.0,
Mode 7.0, CV 0.2, IQR 0.8
Round 2
Statement B: Deﬁnition of Conversion Surgery
A un-planned interruption of laparoscopic maneuvers that requires a laparotomy 93.5%a Round 1
Opposite An extra-corporeal anastomosis is not a criterion for deﬁning conversion surgery 93.3%a Round 2
Statement C: Conversion
Patients intolerance to pneumo-peritoneum is a scenario that requires conversion 80.0%a Round 1
Statement D: Technical Requirements
A laparoscopic colectomy for colon cancer is a surgical procedure which requires a number of devices. Experts community
rated few items and agreed that the following could be assessed, in their experience, as essential
Advanced energy device Range 6e7 77.4%, Mean 6.4, Median 7.0,
Mode 7.0, CV 0.2 IQR 1.0
Round 1
30 scope Range 6e7 76.7%, Mean 5.8, Median 6.0,
Mode 7.0, CV 0.3, IQR 1.0
Round 2
Wound protector/retractor Range 6e7 90.0%, Mean 6.6, Median 7.0,
Mode 7.0, CV 0.1, IQR 0.8
Round 2
Statement E: Oncological Requirements
Laparoscopic procedures for colon cancer should aim to a complete removal of the tumor and of the nodes draining the pedicles, providing an
adequate nodal harvest in accordance with standard and validated principles of surgical oncology; these include
A central vessel ligation for right colon cancer Range 6e7 83.9%, Mean 6.5, Median 7.0.
Mode 7.0, CV 0.25, IQR 0.0
Round 1
A high colon ligation for left colon cancer Range 6e7 76.7%, Mean 6.0, Median 7.0.
Mode 7.0, CV 0.3, IQR 1.0
Round 1
Furthermore Complete Mesocolic Excision is essential in Late Stages Colon Cancers Range 6e7 90.0%, Mean 6.5, Median 7.0,
Mode 7.0, CV 0.2, IQR 0.0
Round 2
Nodal dissection for colon cancer should be performed according to “the embryologically deﬁned
mesocolic planes to create an intact envelope of the mesocolic fascia, and all lymph nodes along the
tumour supplying vessels should be contained in the specimen” (Lancet Oncol 2015; 16: 161e68)
Range 6e7 100.0% Mean 6.9, Median 7.0,
Mode 7.0, CV 0.0, IQR 0.0
Round 4
Statement F: Surgical Reports
Surgical reports should be standardized and, along with a brief description of the procedure, should include a checklist for
Intra-operative tumor location 100.0%a Round 2
Inﬁltration of other organs 100.0%a Round 2
Level of vessel ligations 100.0%a Round 2
Integrity del mesocolon 86.7%a Round 2
Presence of carcinosis 96.4%a Round 3
Type of anastomosis 96.4%a Round 3
Statement G: MIS and EBM
Currently, randomized controlled trials provide level I evidence supporting a better and shorter
postoperative recovery with respect to open surgery for treatment of colon cancer e In Right-Sided
Colon Cancer
Range 6e7 85.7% Mean 6.4, Median 6.5,
Mode 7.0, CV 0.1, IQR 1.0
Round 2
Currently, randomized controlled trials provide level I evidence supporting a better and shorter
postoperative recovery with respect to open surgery for treatment of colon cancer e In Left-Sided
Colon Cancer
Range 6e7 100.0% Mean 6.6, Median 7.0,
Mode 7.0, CV 0.1, IQR 1.0
Round 2
Currently, randomized controlled trials document equal long-term survival outcomes with respect
to open surgery for treatment of colon cancer e In Right-Sided Colon Cancer
Range 6e7 83.3% Mean 6.7, Median 7.0,
Mode 7.0, CV 0.1, IQR 1.0
Round 2
Currently, randomized controlled trials document equal long-term survival outcomes with respect
to open surgery for treatment of colon cancer e In Left-Sided Colon Cancer
Range 6e7 80.0% Mean 6.3, Median 7.0,
Mode 7.0, CV 0.2, IQR 1.0
Round 2
When performed by surgeons experienced in mini-invasive surgery laparoscopic right colectomy
for cancer can be marked as “best practice” in guidelines, should the standard principles of surgical
oncology be respected (R0 procedure, vessel ligation and integrity of the mesocolon)
80.8%a Round 3
When performed by surgeons experienced in mini-invasive surgery laparoscopic left colectomy for
cancer can be marked as “best practice” in guidelines, should the standard principles of surgical
oncology be respected (R0 procedure, vessel ligation and integrity of the mesocolon)
81.5%a Round 3
Statement H: MIS Integrated in the Care of Colon Cancer Patients
The combination of laparoscopy plus enhanced/fast recovery protocols (including but not limited to
integral application of ERAS)
results in better post-operative outcomes comparing open surgery plus the application of the same
protocols
Range 6e7 80.0% Mean 6.2, Median 7.0,
Mode 7.0, CV 0.2, IQR 1.0
Round 2
Clinical studies investigating mini-invasive surgery with respect to the technique employed and
aiming to evaluate the costs should
also measure the “true value” of the procedure. In surgical oncology this outcome should not refer
exclusively to the hospital costs but
should refer to a more articulated notion including functional recovery, patients reported outcomes
and quality of life
Range 6e7 90.0% Mean 6.6, Median 7.0,
Mode 7.0, CV 0.2, IQR 0.0
Round 2
Statement I: MIS and Training
Training in laparoscopic colectomy should be performed exclusively after the fulﬁll of a basic
laparoscopy course (fundamentals would
include knowledge of the equipment and devices and achievement of basic skills e dissection,
cutting, coagulation, and stitching - in
minor procedures i.e. lap appendectomy or cholecystectomy
Range 6e7 93.3% Mean 6.0, Median 7.0,
Mode 7.0, CV 0.1, IQR 1.0
Round 2
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Table 4 (continued )
Statement Consensus Round
Training in laparoscopic colectomy should be coded as a step-by-step procedure which should
include precise “work packages” (i.e.: anatomy
visualization. organ dissection approach. type of anastomosis ect) and “deliveries” (i.e. vascular
ligation, resection, anastomosis etc)
Range 6e7 86.7% Mean 6.1, Median 7.0,
Mode 7.0, CV 0.2, IQR 1.0
Round 2
Training in laparoscopic colectomy should be part of the curriculum in surgical residency programs Range 6e7 76.7% Mean 6.4, Median 7.0,
Mode 7.0, CV 0.1, IQR 1.0
Round 2
Training in laparoscopic colectomy affects the post-operative complication rate (good
training¼good results vs bad/no training¼ worse results)
Range 6e7 80.0% Mean 6.0, Median 7.0,
Mode 7.0, CV 0.3, IQR 1.0
Round 2
A successful training in laparoscopy reduces costs related to the procedure and hospitalization by
reducing the complication rate
Range 6-7 83.3% Mean 6.5, Median 7.0,
Mode 7.0, CV 0.1, IQR 1.0
Round 2
The quality of laparoscopic colectomy training should be measured using pathological endpoints i.e
lymph node harvest and margins
Range 6e7 76.7% Mean 5.7, Median 6.0,
Mode 7.0, CV 0.3, IQR 1.0
Round 2
Training in laparoscopic colectomy for cancer should include attendance to MDTs, basis of diagnosis
(indication and contraindications to
pre-operative tests), understanding the multi-modal treatment (timing and consequences of neo-
adjuvant therapy)
Range 6e7 89.7% Mean 6.6, Median 7.0,
Mode 7.0, CV 0.1, IQR 0.0
Round 2
Statement L: MIS and Quality Assurance
Quality assurance and surgical standards are key elements in order to improve colon cancer patients’ outcomes and includes:
Hospital Volume Range 6e7 75.9% Mean 6.1, Median 6.0,
Mode 7.0, CV 0.2, IQR 1.0
Round 4
Standardized MIS training Range 6e7 89.3% Mean 6.5, Median 7.0,
Mode 7.0, CV 0.1, IQR 1.0
Round 4
a Multiple choice questions.
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performed by surgeons experienced inMIS, laparoscopic colectomy
for cancer should be marked as best practice in guidelines, given
the principles of oncologic surgery be respected (R0 procedure,
vessel ligation and integrity of the mesocolon).
Furthermore, it was documented that laparoscopy is integrated
in the care of colon cancer patients, since experts valued the
opinion that the combination of MIS and enhanced/fast recovery
protocols resulted in better post-operative outcomes comparing
open surgery plus the application of the same protocols.
Finally, at the end of Round 1 the panel was solicited to express
their opinion regarding a possible topic to incorporate as a ﬁnal
domain of interest: the choices included the technical aspects of
surgery (i.e. anastomoses), the beneﬁts and controversies of lapa-
roscopic vs open approach, hospital volumes, costs and training in
laparoscopic colorectal resections. Notably, 96.7% of the responders
selected the training as a possible domain. Accordingly, the latter
was included in the study.
With this domain, the experts outlined a path of that should be
performed exclusively after the fulﬁll of a basic laparoscopy course,
it should be coded as a step-by-step procedure and should be part
of the curriculum in surgical residency programs. Indeed the panel
agreed that a good training in laparoscopic colectomy has a positive
impact on the post-operative complication rate, reduces costs
related to the procedure and hospitalization. Nevertheless also the
training could be measured i.e. using pathological outcomes and
should include the multi-modal cancer treatment.
Round 4was implemented to have a statement focused on quality
assurance: in this ﬁeld experts recognized the hospital volume and a
standardized training as two warrantors of quality in surgical care.
Finally, at the end of each round the experts were asked to rate
the questionnaires and the rate of answer ranging 6e7 responses
(totally like) increased from 69.2% (mean 5.8, median 6.0, SD 0.8)
the end of Round 1e86.2% (mean 6.1, median 6.0, SD 1.1) at the end
of Round 3, documenting a positive feedback on how the comments
from the panel were received and integrated in the study.
Discussion
Despite the results of RCTs in relation to the beneﬁts of MIS, the
rate of laparoscopic colectomies for cancer is still sub-optimal in anumber of countries, or conversely is not reported or investigated
in the vast majority of the Eurozone.
Although it is very difﬁcult to assess what is the optimal rate of
laparoscopic resections for colon cancer we should achieve, we aim
this paper to increase awareness on this topic, possibly to spread
the statements resulted by the expert consensus in order to in-
crease the adoption of MIS in Europe and anywhere else.
Undoubtedly, literature could provide a sufﬁcient amount of
evidences in relation to the short-term outcomes and they are ac-
knowledges by the vast majority of the society guidelines, however,
the impact of these results in clinical practice as the rate of MIS
procedure for colon cancer performed is an emerging problem. On
this basis, randomized controlled trials on laparoscopic surgery
were excluded from the systematic review, because they include
MIS procedures according to the study design but do not reﬂect
daily situation. Accordingly, and in order to avoid biases from
super-specialized centers, we focused on registries and population
based studies, aiming ﬁrstly to highlight the disparities in
geographic variations of results, independently from age, industry
support or hospital quality (due to very heterogeneous literature
impairing this type of analyses). Nevertheless, few of the studies
mirrored the economic status or the health care system (rural
areas) analyzed [39].
However, since “English” language was a mesh term in all the
systematic review searches, few data could have beenmissed, as for
example, results from large multi-institutional Spanish datasets
[67]. On the same extent, we did not examined the quality or did
not have a critical assessment of retrieved publications.
There are a number of reasons to explain the low rate of MIS
procedures: the ﬁrst one is the long training required to achieve a
standard. With the Delphi study, the panel discussed and high-
lighted the key facts that belong to the MIS training and that it
should be included in the core curriculum of the residency, but also
that a good MIS training worth the results in term of reduced
complications and hospitalization. Agreement rates and consensus
were deﬁned at the beginning of each round (Supplement File 3) as
previously described [13,68]; a number of items were also dis-
cussed in relation to this domain, but failed to reach consensus,
among the others: the use of simulators or animal model and the
centralization of training in high volume centers (data not shown).
On the other hand, the necessity to have an accreditation in MIS is
L. Lorenzon et al. / European Journal of Surgical Oncology 44 (2018) 469e483482topic of interest since 72.6% of the experts rated 6e7 on the Liker
scale the following statement: “training in laparoscopic colectomy
should be certiﬁed after a) the completion of a core curriculum with a
minimum number of procedures performed under supervised
mentorship and b) an examination testing knowledge in the various
aspect of patient care (i.e. pathology. presentation and diagnosis,
treatment and communication)”. Over the Rounds different topics
were highly debated among the experts, as for example CME or the
approach to lymphadenectomy: it was agreed that CME should be
mandatory exclusively in late stages (i.e. T3Nþ), although the
clinical stage of a colon cancer is sometimes difﬁcult to assess;
moreover, as far as it concerns nodal dissection, it took the 4th
Rounds to converge on the deﬁnition that it should be performed
according to “the embryologically deﬁned mesocolic planes to
create an intact envelope of the mesocolic fascia, and all lymph
nodes along the tumor supplying vessels should be contained in the
specimen” as deﬁned by Bertelsen and associates [69].
Another issue is the sustainability: however “costs” were
selected as a topic of interests during Round 1 just by 9 experts and
on the other hand the panel agreed with a broad consensus that
nowadays “clinical studies investigating MIS with respect to the
technique employed and aiming to evaluate the costs should also
measure the “true value” of the procedure. In surgical oncology this
outcome should not refer exclusively to the hospital costs but should
refer to a more articulated notion including functional recovery, pa-
tients reported outcomes and quality of life”.
Undoubtedly, laparoscopic colectomy is a surgical procedures
that requires a number of devices, but interestingly the experts
converged just on 3 and the most expensive ones (as HD video
laparoscopy or an integrated laparoscopic integrated room) failed
in reaching a consensus.
As a secondary aim, we herein provide a Position Paper on MIS
for colon cancer: a document providing a deﬁnition, a description
of the technical aspects and of the advantages and pitfalls of a
particular procedure or tool. Although we sometimes discussed
evidences in relation to possible advantages, the aim of this docu-
ment was not to discuss what the evidences are, but how those are
received and are integrated in the clinical practice by a cohort of
leaders in this ﬁeld from different European countries.
Our ﬁndings resulted in 10 consensus statements which sum-
marize the opinion of experts in MIS encompassing 10 different
“domains”.
This manuscript is one of the ﬁrsts to clearly present an insight
into the situation in Europe and beyondwith regard to laparoscopic
colon surgery. Moreover, to the best of our knowledge, this is the
ﬁrst report to provide a clear deﬁnition of MIS colectomy for colon
cancer, when to perform, what is conversion and what are the
minimal essential requirements (from a technical and oncological
point of view), since all these items are often not univocal in
literature.
MIS was deﬁned as “a technique that has been accepted as su-
perior because it produces improved results comparing to those ach-
ieved by other means” for right and left colon cancers and experts
agreed that MIS should be deﬁned as best practice in surgical
oncology guidelines, if the surgeon is experienced and if the prin-
ciples of surgical oncology are respected.
Conclusion
The rate of MIS colectomies for cancer in Europe in under-
reported and it should be further investigated. Using Delphi
methodology, a panel of leaders in this ﬁeld deﬁned laparoscopic
colectomy ad a best practice procedure when performed by an
experienced surgeon respecting the standards of surgical
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